12 Panel Drug Test (CLIA WAIVED) w/FEN- Multi-Panel Urine Screening
12 Panel Drug Test (CLIA WAIVED) w/FEN- Multi-Panel Urine Screening
In Stock
12 Panel Drug Test Cup (CLIA Waived)
with FEN/FYL Detection & Enhanced Sensitivity
Get fast, easy-to-read preliminary screening results with our 12-Panel CLIA Waived Urine Drug Test Cup. This enhanced-sensitivity configuration features lower cutoff levels for select substances, including AMP, COC, and MET.
Each cup contains integrated test panels, an easy-to-secure lid, and a built-in temperature strip for checking specimen temperature at the time of collection.
Designed for convenient screening, results can be read in approximately 5 minutes.
Key Features
- 12-Panel Screening: Tests for AMP, BAR, BZO, BUP, COC, FYL/FEN, MET, MTD, MDMA, OPI, OXY, and THC.
- FDA Cleared & CLIA Waived
- Enhanced Sensitivity: Lower cutoff levels for AMP, COC, and MET.
- FYL/FEN Screening: Includes FYL/FEN at a 1 ng/mL cutoff.
- Fast, Easy-to-Read Results: Clearly marked control and test lines allow for interpretation of preliminary results in approximately 5 minutes.
- Reliable Performance: Built to meet high standards for quality and consistency.
- Secure Lid: Designed to help prevent leaks during handling.
- Built-In Temperature Strip: Helps confirm specimen temperature is within the expected range at the time of collection.
- All-in-One Design: Test strips are integrated directly into the collection cup. No separate dip cards or strips required.
- Individually Packaged: Each test cup is individually sealed for convenient storage and use.
- Extended Shelf Life: Convenient for stocking and ongoing testing needs.
- Fast U.S. Shipping: Orders placed by the cutoff time (3:00 PM ET) typically ship the same business day from our U.S. location.
12-Panel Test Configuration & Cutoff Levels
| Substance | Code | Cutoff Level |
|---|---|---|
| Amphetamines | AMP | 500 ng/mL |
| Barbiturates | BAR | 300 ng/mL |
| Benzodiazepines | BZO | 300 ng/mL |
| Buprenorphine | BUP | 10 ng/mL |
| Cocaine | COC | 150 ng/mL |
| Fen | FYL/FEN | 1 ng/mL |
| Methamphetamine | MET/mAMP | 500 ng/mL |
| Methadone | MTD | 300 ng/mL |
| Ecstasy (MDMA) | MDMA | 500 ng/mL |
| Opiates | OPI300 | 300 ng/mL |
| Oxycodone | OXY | 100 ng/mL |
| Marijuana (THC) | THC | 50 ng/mL |
Enhanced Sensitivity Cutoffs
This configuration uses lower cutoff thresholds for select substances compared with common higher-cutoff test configurations.
| Substance | Common Higher Cutoff | This Cup |
| Amphetamines | 1000 ng/mL | 500 ng/mL |
| Cocaine | 300 ng/mL | 150 ng/mL |
| Methamphetamine | 1000 ng/mL | 500 ng/mL |
Lower cutoff thresholds allow the screening test to detect the targeted drug or metabolite at a lower concentration.
Typical Urine Detection Windows
Detection windows are estimates and should not be interpreted as guaranteed minimum or maximum detection times.
| Substance | Approximate Detection Window |
|---|---|
| Amphetamines | 2–4 days |
| Barbiturates | 1–4 days |
| Benzodiazepines | 1–6 weeks |
| Buprenorphine | 2–6 days |
| Cocaine | 2–7 days |
| FEN | Up to approximately 3 days |
| Methamphetamine | 2–5 days |
| Methadone | 1–3 days |
| Ecstasy (MDMA) | 2–4 days |
| Opiates | 2–4 days |
| Oxycodone | 1–2 days |
| Marijuana (THC) | Up to 14 days or longer depending on frequency of use |
For more information on drug testing, visit SAMHSA Drug Testing FAQ
Clear Results
Each panel contains a Control (C) line and Test (T) line.
- Negative: Two lines appear—one at C and one at T. A faint T line should still be interpreted according to the manufacturer's instructions.
- Preliminary Positive: A C line appears but no T line appears for that substance.
- Invalid: The control (C) line does not appear. The test should be repeated with a new device.
Always refer to the included product instructions before interpreting results.
Ideal For
- Clinical & Professional Settings: CLIA-waived testing for eligible waived testing environments.
- Workplace Screening: Convenient for routine preliminary drug screening programs.
- Treatment & Recovery Programs: All-in-one testing for routine screening needs.
- At-Home Testing: Simple, convenient preliminary screening in one device.
How Urine Drug Screening Works
The integrated test strips use lateral-flow immunoassay technology to detect specific drug metabolites in urine at or above each panel's designated cutoff concentration.
A preliminary positive result should not be considered definitive. When confirmation is required, an appropriate laboratory confirmation method, such as GC-MS or LC-MS/MS, should be used in accordance with applicable procedures.
Important Information
- Results are qualitative and intended for preliminary screening.
- Follow the manufacturer's instructions included with each test.
- Detection times vary by individual and substance.
- Do not use after the expiration date printed on the packaging.
- Store according to the manufacturer's storage instructions.
- Preliminary positive results should be confirmed using an appropriate laboratory method when confirmation is required.
-
FDA Cleared & CLIA Waived: FDA 510(k) clearance numbers K252259 and K261984.
Manufacturer: Assure Tech LLC
*Lid color may vary (blue or white) depending on availability. Product specifications remain the same.